Related Experiment Video
Updated: Apr 23, 2026

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
Cardiovascular Safety of T Cell Engagers: Reassuring Overall, But Not Benign for All
1Department of Cardio-Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Department of Oncological Surgery, Harbin Medical University Cancer Hospital, Harbin, China; Institute of Metabolic Disease, Heilongjiang Academy of Medical Science, Harbin, China; Heilongjiang Key Laboratory for Metabolic Disorder and Cancer Related Cardiovascular Diseases, Harbin, China.
No abstract available in PubMed .
More Related Videos
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025